Neuroventis is an innovative digital health company in neurology, offering patient empowerment, remote monitoring, treatment support, and decentralized trials. Through the Helpilepsy and MigraineManager patient applications and the Neuroventis dashboard, the company connects individuals with epilepsy and headache/migraine to their neurologists. The Neuroventis digital platform, a CE-marked, FDA-registered, ISO13485, and ISO27001 certified medical device software, enables patients to take an active role in their health and supports healthcare professionals in optimizing treatment and enabling early intervention. Founded in 2017 and headquartered in Belgium, Neuroventis received a Non Equity Assistance investment on 12 July 2022 from PharmStars. Collaborating with healthcare professionals, patients, and leading researchers worldwide, Neuroventis is committed to delivering solutions that integrate into patients' and healthcare professionals' lives. For more information, visit Neuroventis.
No recent news or press coverage available for Neuroventis (Helpilepsy & MigraineManager).